Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34570655

Dose-Adjusted Etoposide, Doxorubicin, and Cyclophosphamide With Vincristine and Prednisone Plus Rituximab Therapy in Children and Adolescents With Primary Mediastinal B-Cell Lymphoma: A Multicenter Phase II Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Nov 20
First author
Burke GAA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 Jun 20;40(18):2063-2064. doi: 10.1200/JCO.21.02593.
    note
    Source null
    related pmid
    35377729
    relationship
    Comment in

Authors and identifiers

  1. name
    Burke GAA
    type
    Author
  2. name
    Minard-Colin V
    type
    Author
  3. name
    Aupérin A
    type
    Author
  4. name
    Alexander S
    type
    Author
  5. name
    Pillon M
    type
    Author
  6. name
    Delgado R
    type
    Author
  7. name
    Zsíros J
    type
    Author
  8. name
    Uyttebroeck A
    type
    Author
  9. name
    Dartigues P
    type
    Author
  10. name
    Miles RR
    type
    Author
  11. name
    Kazanowska B
    type
    Author
  12. name
    Chiang AK
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Burke GAA
    type
    Author
  2. name
    Minard-Colin V
    type
    Author
  3. name
    Aupérin A
    type
    Author
  4. name
    Alexander S
    type
    Author
  5. name
    Pillon M
    type
    Author
  6. name
    Delgado R
    type
    Author
  7. name
    Zsíros J
    type
    Author
  8. name
    Uyttebroeck A
    type
    Author
  9. name
    Dartigues P
    type
    Author
  10. name
    Miles RR
    type
    Author
  11. name
    Kazanowska B
    type
    Author
  12. name
    Chiang AK
    type
    Author
bibliography ids
  1. nci-bib-b43925d01abe776a02313ca2
book metadata
content sha256
3a7a1e0ce0bf4ef044a9b7664293775a632eac5d041ed66d8c83db6990e686b4
document type
citation
dois
  1. 10.1200/JCO.21.00920
electronic publication date
display
2021 Sep 27
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34570655
immutable id
pubmed:34570655@3a7a1e0ce0bf4ef044a9b7664293775a632eac5d041ed66d8c83db6990e686b4
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
33
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3716-3724
volume
39
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 Jun 20;40(18):2063-2064. doi: 10.1200/JCO.21.02593.
    note
    Source null
    related pmid
    35377729
    relationship
    Comment in
outcomes validated
false
pmid
34570655
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
71d49b52aeb2dc067cde95b5d6a3370327b10fe04fde1db8501aff37404bcf70
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Nov 20
precision
day
year
2021
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34570655/
title
Dose-Adjusted Etoposide, Doxorubicin, and Cyclophosphamide With Vincristine and Prednisone Plus Rituximab Therapy in Children and Adolescents With Primary Mediastinal B-Cell Lymphoma: A Multicenter Phase II Trial.

Preserved source evidence · Not medical advice